Johnson SC - Search Results

1

Genetic and Clinical Correlates of AI-Based Brain Aging Patterns in Cognitively Unimpaired Individuals.

Skampardoni I, Nasrallah IM, Abdulkadir A, Wen J, Melhem R, Mamourian E, Erus G, Doshi J, Singh A, Yang Z, Cui Y, Hwang G, Ren Z, Pomponio R, Srinivasan D, Govindarajan ST, Parmpi P, Wittfeld K, Grabe HJ, Bülow R, Frenzel S, Tosun D, Bilgel M, An Y, Marcus DS, LaMontagne P, Heckbert SR, Austin TR, Launer LJ, Sotiras A, Espeland MA, Masters CL, Maruff P, Fripp J, Johnson SC, Morris JC, Albert MS, Bryan RN, Yaffe K, Völzke H, Ferrucci L, Benzinger TLS, Ezzati A, Shinohara RT, Fan Y, Resnick SM, Habes M, Wolk D, Shou H, Nikita K, Davatzikos C. Skampardoni I, et al. Among authors: johnson sc. JAMA Psychiatry. 2024 May 1;81(5):456-467. doi: 10.1001/jamapsychiatry.2023.5599. JAMA Psychiatry. 2024. PMID: 38353984

2

Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease.

Toledo JB, Bjerke M, Da X, Landau SM, Foster NL, Jagust W, Jack C Jr, Weiner M, Davatzikos C, Shaw LM, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative Investigators. Toledo JB, et al. JAMA Neurol. 2015 May;72(5):571-81. doi: 10.1001/jamaneurol.2014.4829. JAMA Neurol. 2015. PMID: 25822737 Free PMC article.

3

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.

Zetterberg H, Skillbäck T, Mattsson N, Trojanowski JQ, Portelius E, Shaw LM, Weiner MW, Blennow K; Alzheimer’s Disease Neuroimaging Initiative. Zetterberg H, et al. JAMA Neurol. 2016 Jan;73(1):60-7. doi: 10.1001/jamaneurol.2015.3037. JAMA Neurol. 2016. PMID: 26524180 Free PMC article.

4

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology.

Insel PS, Mattsson N, Mackin RS, Schöll M, Nosheny RL, Tosun D, Donohue MC, Aisen PS, Jagust WJ, Weiner MW; Alzheimer's Disease Neuroimaging Initiative. Insel PS, et al. Neurology. 2016 May 17;86(20):1887-96. doi: 10.1212/WNL.0000000000002683. Epub 2016 Apr 15. Neurology. 2016. PMID: 27164667 Free PMC article.

5

Applying Automated MR-Based Diagnostic Methods to the Memory Clinic: A Prospective Study.

Klöppel S, Peter J, Ludl A, Pilatus A, Maier S, Mader I, Heimbach B, Frings L, Egger K, Dukart J, Schroeter ML, Perneczky R, Häussermann P, Vach W, Urbach H, Teipel S, Hüll M, Abdulkadir A; Alzheimer’s Disease Neuroimaging Initiative. Klöppel S, et al. J Alzheimers Dis. 2015;47(4):939-54. doi: 10.3233/JAD-150334. J Alzheimers Dis. 2015. PMID: 26401773 Free PMC article.

6

Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes.

Schreiber S, Landau SM, Fero A, Schreiber F, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative. Schreiber S, et al. JAMA Neurol. 2015 Oct;72(10):1183-90. doi: 10.1001/jamaneurol.2015.1633. JAMA Neurol. 2015. PMID: 26280102

7

Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy.

Sundermann EE, Biegon A, Rubin LH, Lipton RB, Mowrey W, Landau S, Maki PM; Alzheimer's Disease Neuroimaging Initiative. Sundermann EE, et al. Neurology. 2016 Apr 12;86(15):1368-1376. doi: 10.1212/WNL.0000000000002570. Epub 2016 Mar 16. Neurology. 2016. PMID: 26984945 Free PMC article.

8

Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.

Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M; Alzheimer's Disease Neuroimaging Initiative. Grothe MJ, et al. Neurology. 2017 Feb 7;88(6):569-576. doi: 10.1212/WNL.0000000000003585. Epub 2017 Jan 6. Neurology. 2017. PMID: 28062720 Free PMC article.

9

Quantitative ¹⁸F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients.

Zhao Q, Liu M, Ha L, Zhou Y; Alzheimer's Disease Neuroimaging Initiative. Zhao Q, et al. Front Neurol. 2019 May 15;10:486. doi: 10.3389/fneur.2019.00486. eCollection 2019. Front Neurol. 2019. PMID: 31156534 Free PMC article.

10

Risk Stratification Using Cerebrospinal Fluid Biomarkers in Patients with Mild Cognitive Impairment: An Exploratory Analysis.

Michaud TL, Kane RL, McCarten JR, Gaugler JE, Nyman JA, Kuntz KM; Alzheimer's Disease Neuroimaging Initiative. Michaud TL, et al. J Alzheimers Dis. 2015;47(3):729-40. doi: 10.3233/JAD-150066. J Alzheimers Dis. 2015. PMID: 26401707 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

902 results

Search Page